Impaired fibrinolysis in premenopausal women and age-matched men with Type 2 diabetes mellitus: A pilot study

Journal of Investigative Medicine

Volumn 50, Issue 2, 2002, Pages 110-115

  Brandenburg, Suzanne L ^a   Reusch, Jane E B ^a   Felder, Kimberly K ^a   Nelson Wong, Erica ^a   Lindenfeld, JoAnn ^a   Manco Johnson, Marilyn ^a   Regensteiner, Judith G ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cardiovascular risk factors; Diabetes; Female; Fibrinolysis; Sex differences

Indexed keywords

FIBRINOGEN; HEMOGLOBIN A1C; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; FIBRINOLYSIS; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREMENOPAUSE; RISK FACTOR; SEX DIFFERENCE;

EID: 0036203519     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/6650.2002.31292     Document Type: Article

References (40)

1. The scope of diabetes in the United States population
2. Prevalence of diagnosed diabetes, undiagnosed diabetes, and impaired glucose tolerance in adults 20-74 years of age
3. Diabetes and cardiovascular disease: The Framingham study
4. 5-Year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects
5. Cardiovascular risk factors, premature heart disease, and all-cause mortality in a cohort of northern California women
6. Arteriosclerosis obliterans and associated risk factors in insulin-dependent and non-insulin-dependent diabetes
7. Clustering of heart disease risk factors in diabetic compared to nondiabetic adults
8. A community study of high density lipoproteins in adult noninsulin-dependent diabetics
9. Sex differential in ischemic heart disease mortality in diabetics: A prospective population-based study
10. Closing the gap: The problem of diabetes mellitus in the United States
11. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring study
12. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients
13. Low order correlations of lipoprotein(a) with other blood lipids and with coagulation and fibrinolysis parameters in hypertensive and diabetic patients
14. Euglobulin fibrinolytic activity in NIDDM patients
15. Haemostatic variables and menopausal status: Influence of hormone replacement therapy
16. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women: The Atherosclerosis Risk in Communities Study Investigators
17. The effect of obesity on fibrinolytic activity and plasma lipoprotein(a) levels in patients with type 2 diabetes mellitus in Korea
18. Relationship between plasminogen activator inhibitor type-1 plasma levels and the lipoprotein(a) concentrations in non-insulin-dependent diabetes mellitus
19. Metformin causes a reduction in basal and post-venous occlusion plasminogen activator inhibitor-1 in type 2 diabetic patients
20. Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise
21. Exercise training improves functional status in patients with peripheral arterial disease
22. Age and disease-related alterations in fibrinogen-euglobulin (fibrinolytic) behavior
23. An evaluation of 200 consecutive patients with spontaneous or recurrent thrombosis for primary hypercoagulable states
24. Hypercoagulability and hypofibrinolysis in primary osteoarthritis
25. The euglobulin clot lysis time, a rapid and sensitive method for the assay of fibrinolytic activity after venous stasis
26. Fibrinolytic activity in Chinese patients with diabetes or hyperlipidemia in comparison with healthy controls
27. Insulin sensitivity, insulin action, and fibrinolysis activity in nondiabetic and diabetic obese subjects
28. Haemostasis factors in angina pectoris: Relation to gender, age and acute-phase reaction - Results of the ECAT Angina Pectoris Study Group
29. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1)
30. Rapid physiological coagulation method for the determination of fibrinogen
31. A micro method of euglobulin fibrinolysis in plasma of human subjects and small laboratory animals
32. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction: The PRIME study - Prospective epidemiological study of myocardial infarction
33. Plasminogen-activator inhibitor type 1 and coronary artery disease
34. Increased plasma plasminogen activator inhibitor 1 levels: A possible link between insulin resistance and atherothrombosis
35. Impaired fibrinolytic response to exercise in type II diabetes: Effects of exercise and physical training
36. Hypofibrinolysis associated with vasculopathy in noninsulin dependent diabetes mellitus
37. The relationship between plasminogen activator inhibitor-1 and insulin resistance in newly diagnosed type 2 diabetes mellitus
38. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM
39. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/Progestin Replacement Study (HERS) Research Group